See also under 'mTOR' inhibitors
Last update : 05/05/2012
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar hemorrhage
IV - Airway involvement
V - Pleural and/or pericardial involvement
VI - Pulmonary vasculopathies
VIII - Central-large-upper airway (incl pharyngeal-nasal) involvement
X - Systemic/Distant conditions, syndromes and reactions
XII - Cardiovascular involvement / toxicity
XV - Pathology
XVI - Imaging
XVII - Infections & related conditions
XIX - Cytological, biochemical features of/in BAL, pleural fluid or FNA